Vanda Pharmaceuticals
Price & Volume
Stats
See more52W Range | $3.80-$5.54 |
Market Cap | $301.3M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $203.4M |
Revenue Growth (YoY) | 4.2% |
Gross Profit (12 Mos) | $192M |
Diluted EPS | -$1.14 |
News
See moreYahoo Finance • last month
US High Growth Tech Stocks to Watch This August 2025
Yahoo Finance • 2 months ago
Vanda earnings missed by $0.17, revenue fell short of estimates
Yahoo Finance • 2 months ago
Vanda Pharmaceuticals misses top-line and bottom-line estimates; reaffirms FY25 outlook
Yahoo Finance • 2 months ago
Voice actors push back as AI threatens dubbing industry
About
CEO | Dr. Mihael H. Polymeropoulos M.D. |
CFO | Mr. Kevin Patrick Moran |
Address | 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 368 |
